A Prospective Multicenter Non-interventional Study on Patients and Physicians Satisfaction of Yaz Plus
Phase of Trial: Phase II
Latest Information Update: 11 Aug 2017
Price : $35 *
At a glance
- Drugs Ethinylestradiol/drospirenone/levomefolic acid (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Bayer
- 19 Sep 2016 Status changed from recruiting to completed.
- 03 Aug 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Aug 2016.
- 08 Aug 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.